THEMIS: A Role for Ticagrelor in Diabetic Patients With Prior PCI?

This post was originally published on this site

PARIS — For patients with type 2 diabetes and stable coronary artery disease, the benefits of adding ticagrelor (Brilinta/Brilique, AstraZeneca) to aspirin in terms of reduced ischemic events did not outweigh the bleeding risk in the THEMIS trial. However, there …

Click here to read full article